This study is looking at whether cognitive behavioural therapy can help people with First episode psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a mental health workshop can help people with First episode psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in a mental health workshop and complete follow-up assessments.
This study is looking at whether questionnaires and follow-up can help people with Young people attending NHS mental health services with sleep problems who are at ultra-high-risk of psychosis, Mental and Behavioural Disorders, or Nonorganic sleep disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Latvia
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Latvia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Latvia
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Latvia
Sponsor
Otsuka Pharmaceutical Development & Commercialization,
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.